We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$14.7B
AUM Growth
-$6.7B
(-31%)
Cap. Flow
-$8.87B
Cap. Flow
% of AUM
-60.4%
Top 10 Holdings %
Top 10 Hldgs %
30.89%
Holding
537
New
135
Increased
77
Reduced
139
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$73.6M |
| 2 |
Home Depot
HD
|
+$56.9M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$56.8M |
| 4 |
Emerson Electric
EMR
|
+$55.2M |
| 5 |
Dow Inc
DOW
|
+$35.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$378M |
| 2 |
Apple
AAPL
|
+$293M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$281M |
| 4 |
Alibaba
BABA
|
+$218M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.59% |
| 2 | Technology | 1.73% |
| 3 | Utilities | 1.59% |
| 4 | Financials | 1.34% |
| 5 | Industrials | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTV
351
DELISTED
Innovid Corp.
CTV
| $409K | ﹤0.01% |
290,305
| – | – |
|
352
Phillips 66
PSX
$86B
| $409K | ﹤0.01% |
+4,037
| New | +$410K |
|
353
Procter & Gamble
PG
$340B
| $390K | ﹤0.01% |
+2,622
| New | +$375K |
|
354
Tilray
TLRY
$602M
| $380K | ﹤0.01% |
+15,000
| New | +$428K |
|
|
DMRA
355
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.82B
| $379K | ﹤0.01% |
7,626
| – | – |
|
356
American Express
AXP
$229B
| $368K | ﹤0.01% |
+2,234
| New | +$371K |
|
357
4D Molecular Therapeutics
FDMT
$582M
| $368K | ﹤0.01% |
21,401
| – | – |
|
358
iShares Silver Trust
SLV
$32B
| $356K | ﹤0.01% |
+16,100
| New | +$333K |
|
359
MaxLinear
MXL
$6.21B
| $352K | ﹤0.01% |
10,000
| – | – |
|
|
CDAK
360
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $351K | ﹤0.01% |
2,013,300
| – | – |
|
361
Nextpower Inc
NXT
$15.6B
| $319K | ﹤0.01% |
+8,789
| New | +$278K |
|
362
Altria Group
MO
$109B
| $318K | ﹤0.01% |
+7,129
| New | +$328K |
|
|
NMTR
363
DELISTED
9 Meters Biopharma
NMTR
| $317K | ﹤0.01% |
227,910
| – | – |
|
364
Eaton
ETN
$173B
| $298K | ﹤0.01% |
+1,741
| New | +$290K |
|
365
Centene
CNC
$32.9B
| $296K | ﹤0.01% |
+4,677
| New | +$332K |
|
|
APLT
366
DELISTED
Applied Therapeutics
APLT
| $281K | ﹤0.01% |
345,900
| – | – |
|
367
CALL
TSMC
TSM
$2.17T
| $279K | ﹤0.01% |
3,000
-743,700
| -100% | -$66.8M |
|
368
First Horizon
FHN
$12B
| $273K | ﹤0.01% |
+15,375
| New | +$342K |
|
369
Jefferies Financial Group
JEF
$12.8B
| $264K | ﹤0.01% |
+8,333
| New | +$301K |
|
|
DFS
370
DELISTED
Discover Financial Services
DFS
| $261K | ﹤0.01% |
+2,643
| New | +$283K |
|
371
Leonardo DRS
DRS
$12B
| $256K | ﹤0.01% |
+19,762
| New | +$255K |
|
|
VALN
372
Valneva
VALN
$541M
| $255K | ﹤0.01% |
25,000
| – | – |
|
|
MZTI
373
The Marzetti Company
MZTI
$3.13B
| $252K | ﹤0.01% |
+1,243
| New | +$242K |
|
374
Accenture
ACN
$109B
| $242K | ﹤0.01% |
847
-78,916
| -99% | -$21.5M |
|
|
SQZ
375
DELISTED
SQZ Biotechnologies Company
SQZ
| $242K | ﹤0.01% |
431,400
| – | – |
|
Similar funds
AFM
GCP
LCM
MAP
MA
NSAM
ABI
OCM
Laurion Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Laurion Capital Management held 537 positions worth $14.7B, down 31% from $21.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Laurion Capital Management withdrew a net $8.87B in Q1 2023, closing 111 positions and reducing 139 holdings. Its most notable exit was Amazon, an estimated $378M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 3.4% a quarter earlier, followed by Technology and Utilities.
Against the trend, Laurion Capital Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $72.7M.
- Laurion Capital Management's largest Q1 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 666,036 shares worth $72.7M.
- Laurion Capital Management added most to Altimmune in Q1 2023, an estimated $32.7M increase.
- Laurion Capital Management's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $65.9M.
- Laurion Capital Management fully exited Amazon in Q1 2023, selling an estimated $378M.
- Laurion Capital Management's ten largest holdings make up 31% of its $14.7B portfolio in Q1 2023.
- Laurion Capital Management opened 135 new positions and closed 111 in Q1 2023.
- Laurion Capital Management's portfolio value fell 31% quarter-over-quarter to $14.7B.
Based on Laurion Capital Management's 13F filing for Q1 2023, filed 15 May 2023.